Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether NHS England has developed commissioning policies for treatments procured through a commercial framework agreement.

The Department's Commercial Medicines Unit tenders for medicines framework agreements for use by National Health Service secondary care establishments in England including some where commissioning policies exist. These include:

- Erythrocyte Stimulating Agents;

- Granulocyte Colony Stimulating Factors;

- Anti-retrovirals for HIV;

- Hepatitis C treatments (covered by National Institute for Health and Care Excellence (NICE) Technology Appraisals (TAs));

- Inhaled antibiotics for Cystic Fibrosis;

- Anti-TNF drugs for various indications;

- Immunoglobulins (covered currently by the National Immunoglobulin Guidelines);

- Blood factor products; and

- Drugs used for MS (covered by NICE TAs).